119 related articles for article (PubMed ID: 7947620)
1. [Expression of P-glycoprotein as a multidrug resistance gene product in human reactive astrocytes and astrocytoma].
Dietzmann K; Bossanyi PV; Franke DS
Zentralbl Pathol; 1994 Jul; 140(2):149-53. PubMed ID: 7947620
[TBL] [Abstract][Full Text] [Related]
2. Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas.
Geiger KD; Stoldt P; Schlote W; Derouiche A
Am J Pathol; 2000 Dec; 157(6):1785-93. PubMed ID: 11106550
[TBL] [Abstract][Full Text] [Related]
3. Mdr1 mRNA expression differs between grade III astrocytomas and glioblastomas.
Kirches E; Oda Y; Von Bossanyi P; Diete S; Schneider T; Warich-Kirches M; Dietzmann K
Clin Neuropathol; 1997; 16(1):34-6. PubMed ID: 9020393
[TBL] [Abstract][Full Text] [Related]
4. Expression and distribution of id helix-loop-helix proteins in human astrocytic tumors.
Vandeputte DA; Troost D; Leenstra S; Ijlst-Keizers H; Ramkema M; Bosch DA; Baas F; Das NK; Aronica E
Glia; 2002 Jun; 38(4):329-38. PubMed ID: 12007145
[TBL] [Abstract][Full Text] [Related]
5. Coexpression of epidermal growth factor receptor protein and c-erbB-2 oncoprotein in human astrocytic tumors. An immunohistochemical study.
Dietzmann K; von Bossanyi P
Zentralbl Pathol; 1994 Nov; 140(4-5):335-41. PubMed ID: 7826981
[TBL] [Abstract][Full Text] [Related]
6. WT1 expression distinguishes astrocytic tumor cells from normal and reactive astrocytes.
Schittenhelm J; Mittelbronn M; Nguyen TD; Meyermann R; Beschorner R
Brain Pathol; 2008 Jul; 18(3):344-53. PubMed ID: 18371184
[TBL] [Abstract][Full Text] [Related]
7. Elevated levels of mortalin expression in human brain tumors.
Takano S; Wadhwa R; Yoshii Y; Nose T; Kaul SC; Mitsui Y
Exp Cell Res; 1997 Nov; 237(1):38-45. PubMed ID: 9417864
[TBL] [Abstract][Full Text] [Related]
8. Occurrence of ganglioside GD3 in neoplastic astrocytes. An immunocytochemical study in humans.
Kawai K; Takahashi H; Watarai S; Ishizu H; Fukai K; Tanabe Y; Nose S; Kuroda S
Virchows Arch; 1999 Mar; 434(3):201-5. PubMed ID: 10190298
[TBL] [Abstract][Full Text] [Related]
9. N-cadherin, beta-catenin and connexin 43 expression in astrocytic tumours of various grades.
Reszec J; Szkudlarek M; Hermanowicz A; Bernaczyk PS; Mariak Z; Chyczewski L
Histol Histopathol; 2015 Mar; 30(3):361-71. PubMed ID: 25386667
[TBL] [Abstract][Full Text] [Related]
10. Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration.
Camby I; Belot N; Rorive S; Lefranc F; Maurage CA; Lahm H; Kaltner H; Hadari Y; Ruchoux MM; Brotchi J; Zick Y; Salmon I; Gabius HJ; Kiss R
Brain Pathol; 2001 Jan; 11(1):12-26. PubMed ID: 11145198
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical localization of basic fibroblast growth factor in astrocytomas.
Zagzag D; Miller DC; Sato Y; Rifkin DB; Burstein DE
Cancer Res; 1990 Nov; 50(22):7393-8. PubMed ID: 2171762
[TBL] [Abstract][Full Text] [Related]
12. hTERT immunopositivity patterns in the normal brain and in astrocytic tumors.
Kotoula V; Cheva A; Barbanis S; Papadimitriou CS; Karkavelas G
Acta Neuropathol; 2006 Jun; 111(6):569-78. PubMed ID: 16614861
[TBL] [Abstract][Full Text] [Related]
13. Expression of vascular endothelial growth factor-b in human astrocytoma.
Gollmer JC; Ladoux A; Gioanni J; Paquis P; Dubreuil A; Chatel M; Frelin C
Neuro Oncol; 2000 Apr; 2(2):80-6. PubMed ID: 11303624
[TBL] [Abstract][Full Text] [Related]
14. J1-31 protein expression in astrocytes and astrocytomas.
Shuangshoti S; Thorner PS; Ruangvejvorachai P; Saha B; Groshen S; Taylor CR; Malhotra S; Imam SA
Neuropathology; 2009 Oct; 29(5):521-7. PubMed ID: 19019178
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.
Mishima K; Kato Y; Kaneko MK; Nishikawa R; Hirose T; Matsutani M
Acta Neuropathol; 2006 May; 111(5):483-8. PubMed ID: 16596424
[TBL] [Abstract][Full Text] [Related]
16. The expression of the epitope H recognized by the monoclonal antibody H is higher in astrocytomas compared to anaplastic astrocytomas and glioblastomas.
Arvanitis DL; Arvanitis LD; Panourias IG; Kitsoulis P; Kanavaros P
Histol Histopathol; 2005 Oct; 20(4):1057-63. PubMed ID: 16136487
[TBL] [Abstract][Full Text] [Related]
17. MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors.
Tóth K; Vaughan MM; Peress NS; Slocum HK; Rustum YM
Am J Pathol; 1996 Sep; 149(3):853-8. PubMed ID: 8780389
[TBL] [Abstract][Full Text] [Related]
18. Human malignant astrocytes express macrophage phenotype.
Leenstra S; Das PK; Troost D; de Boer OJ; Bosch DA
J Neuroimmunol; 1995 Jan; 56(1):17-25. PubMed ID: 7822478
[TBL] [Abstract][Full Text] [Related]
19. The glucose transporter and blood-brain barrier of human brain tumors.
Guerin C; Laterra J; Hruban RH; Brem H; Drewes LR; Goldstein GW
Ann Neurol; 1990 Dec; 28(6):758-65. PubMed ID: 2178329
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Eg5 correlates with high grade astrocytic neoplasm.
Liu L; Liu X; Mare M; Dumont AS; Zhang H; Yan D; Xiong Z
J Neurooncol; 2016 Jan; 126(1):77-80. PubMed ID: 26456023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
